1-(4-Bromobenzyl)-3-((tert-butyldimethylsilyl)oxy)azetidine, 98%, 1g

tert-Butyl 1-oxo-4-phenyl-2,8-diazaspiro[4.5]decane-8-carboxylate, 97%, 250mg

4-Isopropylbenzylamine>98.0%(GC)(T)1mL

tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 10g

(S)-1,1,1-Trifluoro-3-methyl-2-butylaminehydrochloride, 97.0%, 1g

DANIRIXIN, 50mg

Oxyde de titane(IV), ROTI®nanoMETIC, min 99,9 %, 4-8 nm, 10 g, emballage en verre

5-QUINOLINEBORONIC ACID PINACOL ESTER, 97.0%, 5g

N,N,3-trimethylbutanamide, 5g

5-Methyl-2-phenyl-1,2-dihydropyrazol-3-one, 95.0%, 100g

Benzamide, N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]-, 98%, 100mg

Ethyl 1,4-diazabicyclo[2.2.2]octane-2-carboxylate dihydrochloride, 98%, 500mg

1-Bromo-6-chloroimidazo[1,5-a]pyridine, 95%, 1g